The yellow zone in asthma treatment: Is it a gray zone?

Annals of Allergy, Asthma and Immunology

Volumn 92, Issue 1, 2004, Pages

  Dinakar, Chitra ^a,b   Reddy, Mamta ^a  

^a CHILDREN S MERCY HOSPITAL   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; DEXAMETHASONE; FLUTICASONE; FLUTICASONE PROPIONATE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; SALBUTAMOL; SALMETEROL;

ASTHMA; CLINICAL PRACTICE; CLINICAL TRIAL; COCHRANE LIBRARY; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HOME CARE; HUMAN; MEDLINE; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 1642536609     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1081-1206(10)61704-8     Document Type: Review

References (45)

1. National Asthma Education and Prevention Program. Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: US Dept of Health and Human Services, National Institutes of Health; 1991. NIH publication 91-3642.
2. National Asthma Education and Prevention Program. Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: US Dept of Health and Human Services, National Institutes of Health; 1997. NIH publication 97-4051.
3. Gibson PG. Monitoring the patient with asthma: an evidence-based approach. J Allergy Clin Immunol. 2000;106:17-26.
4. Asthma in America: survey slide kit. Available at: www.asthmainamerica.com. Accessed July 18, 2001.
5. Weiss ST. Epidemiology and heterogeneity of asthma. Ann Allergy Asthma Immunol. 2001;87(Suppl 1):5-8.
6. Gibson PG, Coughlan J, Wilson AJ, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev. 2000(2):CD001117.
7. Wilson NM, Silverman M. Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home. Arch Dis Child. 1990;65:407-410.
8. Lahdensuo A, Haahtela T, Herrala J, et al. Randomised comparison of guided self management and traditional treatment of asthma over one year. BMJ. 1996;312:748-752.
9. Volovitz B, Nussinovitch M, Finkelstein Y, Harel L, Varsano I. Effectiveness of inhaled corticosteroids in controlling acute asthma exacerbations in children at home. Clin Pediatr (Phila). 2001;40:79-86.
10. Magadle R, Berar-Yanay N, Weiner P. The risk of hospitalization and near-fatal and fatal asthma in relation to the perception of dyspnea. Chest. 2002;121:329-333.
11. Sur S, Crotty TB, Kephart GM, et al. Sudden-onset fatal asthma: a distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis. 1993;148:713-719.
12. Pauwels RA, Lofdahl CG, Postma DS, et al. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med. 1997;337:1405-1411.
13. Lazarus SC, Boushey HA, Fahy JV, et al. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA. 2001;285:2583-2593.
14. Nelson HS, Busse WW, Kerwin E, et al. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. J Allergy Clin Immunol. 2000;106:1088-1095.
15. National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma: update on selected topics 2002. J Allergy Clin Immunol. 2002;110(5 suppl):S141-S219.
16. Travers A, Jones AP, Kelly K, Barker SJ, Camargo CA, Rowe BH. Intravenous beta2 agonists for acute asthma in the emergency department (Cochrane review). Cochrane Database Syst Rev. 2001(2):CD002988.
17. Donahue JG, Weiss ST, Livingston JM, Goetsch MA, Greineder DK, Platt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA. 1997;277:887-891.
18. Levy ML, Stevenson C, Maslen T. Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care. Thorax. 1996;51:1087-1092.
19. DiFranco A, Giannini D, Bartoli ML, et al. Antiinflammatory effect of prednisolone vs. fluticasone propionate in the treatment of moderate exacerbations of asthma as assessed by sputum analysis. Am J Respir Crit Care Med. 1998;157:A869.
20. Nana A, Youngchaiyud P, Charoenratanakul S, et al. High-dose inhaled budesonide may substitute for oral therapy after an acute asthma attack. J Asthma. 1998;35:647-655.
21. Rowe BH, Bota GW, Fabris L, Therrien SA, Milner RA, Jacono J. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial. JAMA. 1999;281:2119-2126.
22. FitzGerald JM, Shragge D, Haddon J, et al. A randomized, controlled trial of high dose, inhaled budesonide versus oral prednisone in patients discharged from the emergency department following an acute asthma exacerbation, Can Respir J. 2000;7:61-67.
23. Lim T. Comparison of inhaled fluticasone propionate and oral prednisolone in the treatment of acute severe asthma. Am J Respir Crit Care Med. 1996;153:A340.
24. Bilancia R, Caputo G, Margiotta D, et al. Oral metil prednisolone vs fluticasone propionate in the treatment of patients hospitalized for middle exacerbation of asthma. Am J Respir Crit Care Med. 1998;157:A403.
25. Nuhoglu Y, Bahceciler NN, Barlan IB, Mujdat Basaran M. The effectiveness of high-dose inhaled budesonide therapy in the treatment of acute asthma exacerbations in children. Ann Allergy Asthma Immunol. 2001;86:318-322.
26. Verona E, Ahel V, Williams L, Medley HV. A multicentre, randomized, double-blind, double-dummy, parallel group study comparing efficacy and safety of fluticasone propionate (FP) 500 mcg BID delivered by metered dose inhaler (MDI) and spacer device with oral soluble prednisolone. Am J Respir Crit Care Med. 1998;157:A711.
27. Connett G, Lenney W. Prevention of viral induced asthma attacks using inhaled budesonide. Arch Dis Child. 1993;68:85-87.
28. Matthews EE, Curtis PD, McLain BI, Morris LS, Turbitt ML. Nebulized budesonide versus oral steroid in severe exacerbations of childhood asthma. Acta Paediatr. 1999;88:841-843.
29. Sano F, Cortez GK, Sole D, Naspitz CK. Inhaled budesonide for the treatment of acute wheezing and dyspnea in children up to 24 months old receiving intravenous hydrocortisone. J Allergy Clin Immunol. 2000;105:699-703.
30. Scarfone RJ, Loiselle JM, Wiley JF II, Decker JM, Henretig FM, Joffe MD. Nebulized dexamethasone versus oral prednisone in the emergency treatment of asthmatic children. Ann Emerg Med. 1995;26:480-486.
31. Sung L, Osmond MH, Klassen TP. Randomized controlled trial of inhaled budesonide as an adjunct to oral prednisone in acute asthma. Acad Emerg Med. 1998;5:209-213.
32. Schuh S, Reisman J, Alshehri M, et al. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. N Engl J Med. 2000;343:689-694.
33. Dockhorn RJ, Baumgartner RA, Leff JA, et al. Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, cross-over study in asthmatic patients. Thorax. 2000;55:260-265.
34. 2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev. 2000(4):CD000060.
35. Everard ML, Bara A, Kurian M, Elliott TM, Ducharme F. Anticholinergic drugs for wheeze in children under the age of two years. Cochrane Database Syst Rev. 2002(1):CD001279.
36. Korosec M, Novak RD, Myers E, Skowronski M, McFadden ER Jr. Salmeterol does not compromise the bronchodilator response to albuterol during acute episodes of asthma. Am J Med. 1999;107:209-213.
37. Peters JI, Shelledy DC, Jones AP Jr, Lawson RW, Davis CP, LeGrand TS. A randomized, placebo-controlled study to evaluate the role of salmeterol in the in-hospital management of asthma. Chest. 2000;118:313-320.
38. Matz J, Emmett A, Rickard K, Kalberg C. Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations. J Allergy Clin Immunol. 2001;107:783-789.
39. Food and Drug Administration. Safety Alert: Serevent (Salmeterol Xinafoate). Washington, DC: Food and Drug Administration; 2003.
40. Storr J, Barrell E, Barry W, Lenney W, Hatcher G. Effect of a single oral dose of prednisolone in acute childhood asthma. Lancet. 1987;1:879-882.
41. Tal A, Levy N, Bearman JE. Methylprednisolone therapy for acute asthma in infants and toddlers: a controlled clinical trial. Pediatrics. 1990;86:350-356.
42. Scarfone RJ, Fuchs SM, Nager AL, Shane SA. Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma. Pediatrics. 1993;92:513-518.
43. Harris JB, Weinberger MM, Nassif E, Smith G, Milavetz G, Stillerman A. Early intervention with short courses of prednisone to prevent progression of asthma in ambulatory patients incompletely responsive to bronchodilators. J Pediatr. 1987;110:627-633.
44. Hendeles L, Sherman J. Are inhaled corticosteroids effective for acute exacerbations of asthma in children? J Pediatr. 2003;142(Suppl):S26-S33.
45. Rodrigo G, Rodrigo C. Inhaled flunisolide for acute severe asthma. Am J Respir Crit Care Med. 1998;157:698-703.